Medicare Enrolled
Dr. Alison Rome, MD
Hematology & Oncology · Houston, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rome from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rome?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rome
Dr. Alison Rome is a hematology & oncology specialist in Houston, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Rome performed 735 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Rome received a total of $10,390 from 77 pharmaceutical and/or device companies across 437 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rome is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ 735 Medicare services
$10,390 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗735
Medicare services
Bottom 41% in TX for hematology & oncology
Not available
Unique patients (not deduplicated)
$64
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
233 | $63 | $247 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
86 | $98 | $368 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
85 | $8 | $20 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
79 | $8 | $36 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
47 | $104 | $470 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
44 | $10 | $64 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
36 | $102 | $707 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
35 | $96 | $357 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
30 | $138 | $496 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
25 | $124 | $565 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
20 | $41 | $313 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
15 | $140 | $694 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
7.6% high complexity
0.0% medium
92.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$10,390
Total received (2018-2024)
Avg $1,484/year across 7 years
Top 31% in TX for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
77
Companies
437
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,649
2023
$2,343
2022
$520
2021
$12
2020
$437
2019
$1,772
2018
$1,658
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$932
PFIZER INC.
$287
AstraZeneca Pharmaceuticals LP
$224
Janssen Biotech, Inc.
$210
E.R. Squibb & Sons, L.L.C.
$161
Merck Sharp & Dohme LLC
$151
GlaxoSmithKline, LLC.
$145
Celgene Corporation
$119
Astellas Pharma US Inc
$114
Gilead Sciences, Inc.
$89
SOBI, INC
$69
GENZYME CORPORATION
$61
JAZZ PHARMACEUTICALS INC.
$60
Lilly USA, LLC
$58
Genentech USA, Inc.
$57
Deciphera Pharmaceuticals Inc.
$55
PharmaEssentia USA Corporation
$55
Takeda Pharmaceuticals U.S.A., Inc.
$53
Daiichi Sankyo Inc.
$50
ABBVIE INC.
$50
BeiGene USA, Inc.
$49
TAIHO ONCOLOGY, INC.
$48
SpringWorks Therapeutics, Inc.
$46
Tempus AI, Inc
$43
Alexion Pharmaceuticals, Inc.
$39
Eisai Inc.
$37
PUMA BIOTECHNOLOGY, INC.
$36
Boston Scientific Corporation
$34
Ipsen Biopharmaceuticals, Inc
$33
Bayer Healthcare Pharmaceuticals Inc.
$30
EMD Serono, Inc.
$29
ARRAY BIOPHARMA INC
$29
Aveo Pharmaceuticals, Inc.
$28
Fennec Pharmaceuticals, Inc.
$27
Sirtex Medical Inc
$25
Regeneron Healthcare Solutions, Inc.
$24
Myriad Genetic Laboratories, Inc.
$22
Karyopharm Therapeutics Inc.
$20
Incyte Corporation
$19
Rigel Pharmaceuticals, Inc.
$17
Exelixis Inc.
$16
Top 3 companies account for 39.5% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,382
PFIZER INC.
$806
Amgen Inc.
$663
AstraZeneca Pharmaceuticals LP
$615
E.R. Squibb & Sons, L.L.C.
$601
Genentech USA, Inc.
$550
Janssen Biotech, Inc.
$387
Astellas Pharma US Inc
$375
Merck Sharp & Dohme LLC
$303
Celgene Corporation
$255
GENZYME CORPORATION
$246
Lilly USA, LLC
$241
Merck Sharp & Dohme Corporation
$236
GlaxoSmithKline, LLC.
$201
Gilead Sciences, Inc.
$185
Ipsen Biopharmaceuticals, Inc
$176
PharmaEssentia USA Corporation
$162
Daiichi Sankyo Inc.
$157
TESARO, Inc.
$143
Rigel Pharmaceuticals, Inc.
$133
SOBI, INC
$127
Eisai Inc.
$116
TerSera Therapeutics LLC
$112
TAIHO ONCOLOGY, INC.
$104
Takeda Pharmaceuticals U.S.A., Inc.
$102
SANOFI-AVENTIS U.S. LLC
$100
Boehringer Ingelheim Pharmaceuticals, Inc.
$84
Bayer HealthCare Pharmaceuticals Inc.
$78
Dendreon Pharmaceuticals LLC
$78
Deciphera Pharmaceuticals Inc.
$74
EMD Serono, Inc.
$72
Exelixis Inc.
$70
PUMA BIOTECHNOLOGY, INC.
$61
JAZZ PHARMACEUTICALS INC.
$60
Alexion Pharmaceuticals, Inc.
$59
Pharmacyclics LLC, An AbbVie Company
$59
Janssen Pharmaceuticals, Inc
$59
Pharming Healthcare, Inc.
$58
Seagen Inc.
$54
Incyte Corporation
$52
ABBVIE INC.
$50
EISAI INC.
$49
BeiGene USA, Inc.
$49
SpringWorks Therapeutics, Inc.
$46
Tempus AI, Inc
$43
Regeneron Healthcare Solutions, Inc.
$42
Jazz Pharmaceuticals Inc.
$42
MorphoSys, US Inc.
$36
Boston Scientific Corporation
$34
Puma Biotechnology, Inc.
$32
Kite Pharma, Inc.
$31
AVEO Pharmaceuticals, Inc.
$30
Bayer Healthcare Pharmaceuticals Inc.
$30
ARRAY BIOPHARMA INC
$29
Aveo Pharmaceuticals, Inc.
$28
Fennec Pharmaceuticals, Inc.
$27
Pharmacosmos Therapeutics Inc.
$27
Sirtex Medical Inc
$25
AbbVie Inc.
$24
Octapharma USA, Inc.
$23
Immunocore Limited
$22
Myriad Genetic Laboratories, Inc.
$22
Karyopharm Therapeutics Inc.
$20
AMAG Pharmaceuticals, Inc.
$20
Global Blood Therapeutics, Inc.
$20
APO-PHARMA USA, INC.
$19
Teva Pharmaceuticals USA, Inc.
$19
Blueprint Medicines Corporation
$18
Clovis Oncology, Inc.
$17
Agios Pharmaceuticals, Inc.
$17
Mirati Therapeutics, Inc.
$16
INSYS Therapeutics Inc
$15
Aurobindo Pharma USA, Inc.
$15
Mylan Institutional Inc.
$15
Akcea Therapeutics, Inc.
$14
Tactile Systems Technology Inc
$14
Acrotech Biopharma LLC
$12
Top 3 companies account for 27.4% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALIMTA · ALUNBRIG · AYVAKIT · Abraxane · Alecensa · Aranesp · Avastin · BELEODAQ · BENDEKA · BESREMI · BOSULIF · BRACANALYSIS CDX · BRUKINSA · Bavencio · Beleodaq · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CHANTIX · CYRAMZA · Cabometyx · Columvi · DARZALEX · DOPTELET · Doptelet · ELELYSO · ELIQUIS · ELREXFIO · ENHERTU · ENJAYMO · ERBITUX · ERLEADA · Enhertu · Erleada · FERAHEME · FERRIPROX · FLEXITOUCH · FOTIVDA · FRUZAQLA · Fabhalta · Fulphila · GILOTRIF · Halaven · IBRANCE · IDHIFA · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Imbruvica · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MONOFERRIC · NERLYNX · Neulasta · Nexavar · Nplate · OCTAPLAS · OGSIVEO · OJJAARA · OPDIVO · OPDUALAG · OXBRYTA · Onivyde · PADCEV · PROMACTA · PROVENGE · Padcev · Pedmark · Perjeta · Pomalyst · Prolia · QINLOCK · REBLOZYL · RETEVMO · RUCONEST · RYBREVANT · RYDAPT · Rezlidhia · Rubraca · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYNDROS · Somatuline Depot · Stivarga · TABRECTA · TAGRISSO · TECENTRIQ · TECVAYLI · TEGSEDI · Tavalisse · TheraSphere Y90 Glass Microspheres 10 GBq · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · VYXEOS · Vectibix · Venclexta · Vyloy · XALKORI · XARELTO · XPOVIO · XT CDX · XTANDI · Xospata · Xtandi · ZEJULA · ZEPZELCA · ZOLADEX
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
197
County median income
$73,104
Nearest hospital to ZIP centroid (approximate)
HCA HOUSTON HEALTHCARE SOUTHEAST
4.7 mi
4.7 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Rome is a clinical cardiology specialist, with moderate Medicare volume, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Rome experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Rome performed 233 hospital follow-up visit, moderate complexity services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Rome receive payments from pharmaceutical companies?
Yes. Dr. Rome received a total of $10,390 from 77 companies across 437 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rome's costs compare to other hematology & oncology specialists in Houston?
Dr. Rome's average Medicare payment per service is $64. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rome) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Houston
Browse hematology & oncology specialists in Houston ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in TX
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in TX
Which TX hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology